Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus

Fig. 4

Associations between attainment of LLDAS after 6 months and levels of a, b anti-SSA/Ro52, c, d anti-SSA/Ro60, and e, f anti-SSB/La in a, c, e sera where data were obtained with conventional measurements and b, d, f in the corresponding solubilized IC. Horizontal lines illustrate median levels, with corresponding values presented below each measure. ns not significant, LLDAS low lupus disease activity state

Back to article page